Alzheimers Disease: - Evotec Successfully Completes Phase I for Potential Alzheimer’s …
Thursday, August 31st, 2006Evotec Successfully Completes Phase I for Potential Alzheimer’s …
Yahoo! News (press release) - Aug 8, 2006… announced the successful completion of Phase I with EVT 101, an NR2B subtype-specific NMDA receptor antagonist for the treatment of Alzheimer’s disease and/or …